Wellgistics Opens a $50M Ripple (XRP) Line for Pharmacies While Ruvi (RUVI) Fills Phase 3 at $0.020

Wellgistics Health (Nasdaq: WGRX) has opened a $50 million credit facility to deploy XRP payments across more than 6,000 US pharmacies, the first pharmaceutical distribution application of XRP in the United States. With XRP trading near $1.14, the move puts Ripple's settlement rails inside a regulated supply chain. Meanwhile, some investors are also turning toward the Ruvi (RUVI) decentralized AI superapp (ruvi.io https://ruvi.io), an audited platform already running 20+ live AI models that pays contributors in $RUVI for the training work they hand closed apps for free.

A Product That Ships, Not a Roadmap That Promises

Most presales sell a roadmap; Ruvi sells a product that already works: 20+ AI models live across text, image, video, and audio, audited, with a fixed 5B non-mintable supply. The technical architecture ties that product to the token. Ruvi connects AI infrastructure to a tokenized economy where $RUVI meters every generation across web and mobile, and where usage, rankings, and contributions feed directly back into the network. Critical ecosystem activity stays publicly verifiable on-chain, so supply, holders, and burns can be checked rather than trusted. XRP moves value between pharmacies; $RUVI is the economic layer powering an AI ecosystem people actually use.

Why Capital Rotates From XRP Into Ruvi

The Wellgistics line is real adoption, but XRP holders capture none of the fees the network settles. Pharmacy payments flow through Ripple; token holders watch from the sidelines. That structural gap is exactly what Ruvi was designed to close. Every prompt run through the AI tool suite meters $RUVI, every model improvement by a contributor pays out in $RUVI, and every dollar of platform revenue funds an on-chain buyback. As XRP processes payments it cannot redistribute to holders, capital is rotating before the end of the presale because the contributor-payout difference is obvious and verifiable.

The Math On a $500 Position Before Phase 3 Fills

Phase 3 is live at $0.020 after Phases 1 ($0.010) and 2 ($0.015) sold out, with Phase 4 stepping to $0.028. A $500 position at $0.020 buys 25,000 $RUVI, worth $2,500 at the $0.10 listing target. That 25,000 already clears VIP 1 for a +20% bonus, an extra 5,000 $RUVI before listing. Once Phase 3 fills, the same $500 at the $0.028 Phase 4 price buys 17,857, which is 7,143 fewer $RUVI for the same money. Post-presale, $RUVI staking is set to pay roughly 6% to 14% APY from real platform revenue, so the position keeps working while the listing target approaches. The 5 billion supply is fixed and non-mintable, and platform revenue funds an on-chain buyback-and-burn: as usage rises, the circulating supply falls. While XRP settles payments it cannot return to holders, Ruvi is shipping a product today.

Conclusion

XRP can move pharmacy payments, but it returns none of that fee revenue to the people holding it. Ruvi is an audited, shipping AI superapp at $0.020 with 20+ live models, 3,000+ holders, and a fixed 5B non-mintable supply burning on-chain. Phase 3 is filling now and steps to $0.028 the moment it closes. Take a position at ruvi.io https://ruvi.io before Phase 3 closes and today's entry becomes the floor. Full token economics are at docs.ruvi.io https://docs.ruvi.io.

FAQs

What does the Wellgistics deal mean for XRP? Wellgistics Health opened a $50 million facility to run XRP payments across more than 6,000 US pharmacies, the first such pharmaceutical use in the country. With XRP near $1.14, it is real adoption, though network fees still bypass token holders.

Why are XRP holders looking at Ruvi? XRP settles value but captures no revenue for holders. Ruvi pays contributors in $RUVI for AI training and funds on-chain buyback-and-burn from real usage, giving holders exposure to ecosystem activity.

Is the Ruvi presale legitimate and what do buyers receive? Ruvi is audited, with a fixed 5B non-mintable supply that is on-chain and publicly verifiable, tracked on CoinMarketCap, and backed by 3,000+ holders. Buyers receive $RUVI at the live phase price with 100% unlock at launch, no cliff or vesting.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Cryptocurrency investments are highly volatile and involve significant risk, including the potential loss of principal. Always perform your own due diligence or consult a licensed financial advisor before making investment decisions.

Ruvi AI
contact@ruvi.io
https://ruvi.io

Ruvi is a decentralized AI superapp combining generative AI tools (text, image, video, audio) behind a single unified product. $RUVI powers a user-in-the-loop training economy where contributors earn for improving the platform. Fixed 5B supply, non-mintable. Platform revenue funds permanent on-chain buyback and burn. https://ruvi.io

This release was published on openPR.